{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:15:16Z","timestamp":1783142116911,"version":"3.54.6"},"reference-count":25,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2026,6,30]]},"DOI":"10.7883\/yoken.jjid.2025.266","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:10:42Z","timestamp":1782771042000},"source":"Crossref","is-referenced-by-count":0,"title":["Pre- vaccination seroprevalence of rubella IgM among women of child bearing age in southeast Nigeria: a five-year cross-sectional study"],"prefix":"10.7883","author":[{"given":"Chinedu Michael","family":"Chukwubike","sequence":"first","affiliation":[{"name":"Molecular Virology Unit, Microbiology Department, University of Nigeria Teaching Hospital Ituku-Ozalla, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chioma Uju","family":"Benjamin-Puja","sequence":"additional","affiliation":[{"name":"Molecular Virology Unit, Microbiology Department, University of Nigeria Teaching Hospital Ituku-Ozalla, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance Ugochi","family":"Azubuike","sequence":"additional","affiliation":[{"name":"Molecular Virology Unit, Microbiology Department, University of Nigeria Teaching Hospital Ituku-Ozalla, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chioma Chinyere","family":"Edu-Alamba","sequence":"additional","affiliation":[{"name":"Molecular Virology Unit, Microbiology Department, University of Nigeria Teaching Hospital Ituku-Ozalla, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elezuo Okorie","family":"Elezuo","sequence":"additional","affiliation":[{"name":"Epidemiology and Health Research Unit, Dept of Public Health and Disease Control, Abia State Ministry of Health Umuahia, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuma","family":"Emembolu","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, Department of Public Health, Anambra State Ministry of Health, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogbonna","family":"Nwabeke","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, Department of Public Health, Ebonyi State Ministry of Health, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okechukwu","family":"Ogbodo","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, Department of Public Health, Enugu State Ministry of Health, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyacinth","family":"Egbuna","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, Department of Public Health, Imo State Ministry of Health, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Princess Ada","family":"Ojeanyah","sequence":"additional","affiliation":[{"name":"Molecular Virology Unit, Microbiology Department, University of Nigeria Teaching Hospital Ituku-Ozalla, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Ifeoma","family":"Ajaegbu","sequence":"additional","affiliation":[{"name":"Molecular Virology Unit, Microbiology Department, University of Nigeria Teaching Hospital Ituku-Ozalla, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinenye","family":"Ibeh","sequence":"additional","affiliation":[{"name":"Molecular Virology Unit, Microbiology Department, University of Nigeria Teaching Hospital Ituku-Ozalla, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluchi Obioma","family":"Adighogu","sequence":"additional","affiliation":[{"name":"Epidemiology and Health Research Unit, Dept of Public Health and Disease Control, Abia State Ministry of Health Umuahia, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika David","family":"Okudoh","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, Department of Public Health, Anambra State Ministry of Health, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseline","family":"Adolphus-Chukwuemeka","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, Department of Public Health, Enugu State Ministry of Health, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Ihedioha","sequence":"additional","affiliation":[{"name":"Public Health Emergency Operation Unit, Public Health Department, Imo State Ministry of Health, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abudullahi","family":"Salihu","sequence":"additional","affiliation":[{"name":"Disease Prevention and Control, Vaccine Preventable Diseases Unit, World Health Organization Country Office, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blessing","family":"Ekanem","sequence":"additional","affiliation":[{"name":"Disease Prevention and Control, Vaccine Preventable Diseases Unit, World Health Organization Country Office, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Chukwuji","sequence":"additional","affiliation":[{"name":"Disease Prevention and Control, Vaccine Preventable Diseases Unit, World Health Organization Country Office, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olajumoke","family":"Babatunde","sequence":"additional","affiliation":[{"name":"Public Health Laboratory Services, Nigerian Centre of Disease Control and Prevention, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Indyeriyo-Kaan Dooshima","sequence":"additional","affiliation":[{"name":"Public Health Laboratory Services, Nigerian Centre of Disease Control and Prevention, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","unstructured":"1. Centers for Disease Control and Prevention (CDC). Clinical overview of Rubella (German Measles, Three-Day Measles). Atlanta (GA): Available at &lt;https:\/\/www.cdc.gov\/rubella\/hcp\/clinical-overview\/index.html&gt; Accessed January 23, 2026."},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Pereira L. Congenital viral infection: Traversing the uterine-placental interface. Annu Rev Virol, 5(1), 273\u2013299. doi:10.1146\/annurev-virology-092917-043236","DOI":"10.1146\/annurev-virology-092917-043236"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. De Melo LC, Rugna MM, Dur\u00e3es TA, et al. Congenital rubella syndrome in the post-elimination era: Why vigilance remains essential. J Clin Med, 14(11), 3986. doi:10.3390\/jcm14113986","DOI":"10.3390\/jcm14113986"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Kaushik A, Verma S, Kumar P. Congenital rubella syndrome: A brief review of public health perspectives. Indian J Public Health, 62(1), 52\u201354. doi:10.4103\/ijph.IJPH_275_16","DOI":"10.4103\/ijph.IJPH_275_16"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Yazigi A, De Pecoulas AE, Vauloup Fellous C, et al. Fetal and neonatal abnormalities due to congenital rubella syndrome: a review of literature. J Matern Fetal Neonatal Med. 2017;30(3):274 278. doi:10.3109\/14767058.2016.1169526.","DOI":"10.3109\/14767058.2016.1169526"},{"key":"6","unstructured":"6. World Health Organization. Rubella. WHO Immunization, Vaccines and Biologicals. Available at: &lt;https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/diseases\/rubella&gt;. Accessed January 27, 2026."},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Ben Moussa, M.L., Hamdoun, M., Cherni, H. et al. Rubella seroprevalence among women of childbearing age in Tunis, Tunisia. BMC Infect Dis 25, 470 (2025). https:\/\/doi.org\/10.1186\/s12879-025-10843-4","DOI":"10.1186\/s12879-025-10843-4"},{"key":"8","unstructured":"8. World Health Organization. Congenital rubella syndrome (CRS) reported cases and incidence. Available at: &lt;https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/congenital-rubella-syndrome-(crs)-reported-cases-and-incidence-by-year&gt;. Accessed November 21, 2025."},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Rodriguez-Cartes SA, Zhang Y, Mayorga ME, et al. Evaluating the potential impact of rubella-containing vaccine introduction on congenital rubella syndrome in Afghanistan, Dem. Republic of Congo, Ethiopia, Nigeria, and Pakistan: a mathematical modeling study. PLOS Glob Public Health. 2024;4:e0002656. doi: https:\/\/doi.org\/10.1371\/journal.pgph.0002656.","DOI":"10.1371\/journal.pgph.0002656"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Alleman MM, Wannemuehler KA, Hao L, et al. Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: potential impact on vaccination policy. Vaccine. 2016;34:6502\u20136511. doi: https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.059.","DOI":"10.1016\/j.vaccine.2016.10.059"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Luce R, Masresha BG, Katsande R, et al. The impact of recent rubella vaccine introduction in 5 countries in the African region. J Immunol Sci. 2018;Suppl 16:108\u2013112.","DOI":"10.29245\/2578-3009\/2018\/si.1116"},{"key":"12","unstructured":"12. World Health Organization Regional Office for Africa. Nigeria launches large-scale vaccination campaign to protect 106 million children against measles, rubella and polio. Available at: &lt;https:\/\/www.afro.who.int\/countries\/nigeria\/news\/nigeria-launches-large-scale-vaccination-campaign-protect-106-million-children-against-measles&gt;. Accessed December 1, 2025."},{"key":"13","unstructured":"13. National Bureau of Statistics. Reports. Abuja: NBS. Available at: &lt;https:\/\/www.nigerianstat.gov.ng\/elibrary\/read\/1241422&gt;. Accessed January 24, 2026."},{"key":"14","unstructured":"14. World Health Organization. Measles and rubella laboratory network. Available at &lt;https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/immunization-analysis-and-insights\/surveillance\/surveillance-for-vpds\/laboratory-networks\/measles-and-rubella-laboratory-network&gt; Accessed December 1, 2025."},{"key":"15","unstructured":"15. Euroimmun. Anti-Rubella Virus ELISA (IgM) \u2013 Instructions for use. L\u00fcbeck, Germany: Euroimmun Medizinische Labordiagnostika AG; n.d. Available at &lt;https:\/\/intimakmur.co.id\/uploads\/files\/produk\/ifu\/20210715052436-ifu-anti-rubella-virus-elisa-igm.pdf&gt; Accessed December 2, 2025."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nguessan CK, Agbo SK, Traore Y, Gourmanon C, Ekra DK, et al. Rubella case detection through the measles surveillance system from 2012 to 2016 in C\u00f4te d\u2019Ivoire. Int J Trop Dis. 2018;1:001.","DOI":"10.23937\/ijtd-2017\/1710001"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Nimpa Mengouo M, Ndze VN, Baonga F, Kobela M, Njouom R, Wiysonge CS, et al. Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008\u20132014. BMJ Open. 2017;7:e012959. doi:10.1136\/bmjopen-2016-012959.","DOI":"10.1136\/bmjopen-2016-012959"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Gemechu DS, Worku Y, Edae ZA, Feyisa YD, Watere SH, Woyessa AB, et al. Epidemiological analysis of rubella-confirmed cases from measles-suspected cases in Ethiopia: threat for congenital rubella syndrome. Epidemiol Infect. 2022;150:e55. doi:10.1017\/S0950268822000279.","DOI":"10.1017\/S0950268822000279"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Hong H, Malfeld S, Smit S, Makhathini L, Fortuin M, Motsamai T, et al. A retrospective 5\u2011year review of rubella in South Africa prior to the introduction of a rubella\u2011containing vaccine. PLoS One. 2022;17(5):e0265870. doi:10.1371\/journal.pone.0265870.","DOI":"10.1371\/journal.pone.0265870"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Bagenda F, Mulogo EM, Apecu RO, Kisakye A, Opar BT. Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda. BMC Infect Dis. 2020;20(1):219. doi:10.1186\/s12879-020-4928-9.","DOI":"10.1186\/s12879-020-4928-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kolude O, Emmanuel EE, Ajayi P, Ilesanmi M, Ibikunle F, Onwu VA, et al. Rising incidence of rubella among patients with febrile rash illness in a southwestern state of Nigeria: a ten-year review. Am J Clin Res Rev. 2020;4:16.","DOI":"10.28933\/ajcrr-2020-01-2105"},{"key":"22","unstructured":"22. World Health Organization. Surveillance standards for vaccine-preventable diseases: congenital rubella syndrome (CRS). Geneva: World Health Organization; 2018. Available at: &lt;https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/vpd_surveillance\/vpd-surveillance-standards-publication\/who-surveillancevaccinepreventable-03-crs-r2.pdf&gt; Accessed January 23 2026."},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Masresha B, Luce R, Katsande R, Dosseh A, Tanifum P, Lebo E, et al. The impact of the COVID\u201119 pandemic on measles surveillance in the World Health Organisation African Region, 2020. Pan Afr Med J. 2021;39:192. doi:10.11604\/pamj.2021.39.192.29491","DOI":"10.11604\/pamj.2021.39.192.29491"},{"key":"24","unstructured":"24. Durowade KA. Epidemiological pattern of rubella in Africa: a review of selected Sub-Saharan African countries. Niger J Med. 2022;63(5):340\u20117."},{"key":"25","unstructured":"25. World Health Organization. Provisional monthly measles and rubella data. WHO Immunization Analysis and Insights Unit. Available at: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/immunization-analysis-and-insights\/surveillance\/monitoring\/provisional-monthly-measles-and-rubella-data. Accessed January 26, 2026."}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/advpub\/0\/advpub_JJID.2025.266\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:17:23Z","timestamp":1783138643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/advpub\/0\/advpub_JJID.2025.266\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2025.266","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"article-number":"JJID.2025.266"}}